Back to search

Finland· FI-REL-REL2512

Didronate+Calcium

A etidronsäure und calcium, sequenzialpräparate product containing etidronic acid + calcium carbonate, registered in Finland by Warner Chilcott UK Limited.

ATC M05BB01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedDidronate+CalciumATCM05BB01REGISTER NO.FI-REL-REL2512PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Etidronic acid + Calcium carbonate
Manufacturer
Warner Chilcott UK Limited
Country
Finland (FI)
ATC code
M05BB01
ATC class
Etidronsäure und Calcium, Sequenzialpräparate
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b0dd05c3-b75a-4cf6-b82a-03f71d2776b9
GET /v1/drugs/b0dd05c3-b75a-4cf6-b82a-03f71d2776b9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.4",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "400 mg / 500 mg",
  "atc_label": "etidronaatti ja kalsium",
  "ma_number": "12106",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2512",
  "authorised_at": "1996-07-29"
}

See everything about etidronsäure und calcium, sequenzialpräparate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.